A blockchain-based medical sample full-life-cycle trusted traceability system and method

Abstract

This invention discloses a blockchain-based trusted traceability system and method for the entire lifecycle of medical samples, belonging to the fields of medical sample management, blockchain, and edge computing technologies. The system includes a data acquisition unit, an edge verification unit, a blockchain evidence storage unit, and an intelligent control and interaction unit. The data acquisition unit implements unique sample identification binding and full-process data acquisition, supporting local caching even when offline. The edge verification unit performs data validity verification and anomaly filtering. The blockchain evidence storage unit adopts a consortium blockchain architecture, storing hash digests, dual timestamps, and digital signatures on-chain, while original sensitive data is encrypted and stored in an off-chain distributed file system. The intelligent control and interaction unit implements access control, traceability query, and anomaly output. This invention achieves trusted traceability and privacy compliance for the entire lifecycle of medical samples through real-time edge filtering, off-chain encryption and on-chain hashing, and offline dual timestamp calibration.

Description

Technical Field

[0001] This invention relates to the fields of medical sample management, blockchain, edge computing, data security and human-computer interaction. Specifically, it is a blockchain-based trusted traceability system and method for the entire lifecycle of medical samples, which is particularly suitable for medical sample management scenarios that require high compliance, strong trust and lightweight implementation. Background Technology

[0002] Medical samples are the core carriers of clinical diagnosis and scientific research analysis, and the authenticity of data, environmental security, and privacy compliance during their transfer directly determine the quality of medical care. Current technologies generally suffer from the following shortcomings: Centralized architectures are easily tampered with, resulting in low data reliability; The anomaly verification mechanism is fixed, and its protection scope is limited; In scenarios where the network is offline, data reliability is insufficient and there is a lack of effective calibration mechanisms; The storage of sensitive medical data does not meet regulatory requirements and makes it difficult to meet compliance needs such as data deletion. The lack of technically solidified means for identifying abnormal liability makes evidence collection and tracing difficult. Summary of the Invention

[0003] Technical issues

[0004] This invention addresses the problems of insufficient data credibility, limited scope of anomaly verification and protection, poor adaptability to offline scenarios, weak privacy compliance, and difficulty in liability determination in existing medical sample traceability systems. It provides a blockchain-based trusted traceability system and method for the entire lifecycle of medical samples, achieving reliable traceability and compliant management through hardware support and technological collaboration.

[0005] Technical solution

[0006] 1. System Overall Structure

[0007] A blockchain-based trusted traceability system for the entire lifecycle of medical samples, comprising: 1) Data acquisition unit (1): includes processor, memory, tamper-proof electronic identification module (RFID / NFC), multi-source environmental sensor; physical anti-tampering, unique identifier for lifelong binding, local caching when offline, and data with digital signature.

[0008] 2) Edge verification unit (2): includes edge computing chip, memory and program module; based on data fluctuation characteristics and heartbeat signal verification, it supports multiple algorithms, and blocks the on-chain process if there is an anomaly.

[0009] 3) Blockchain Evidence Storage Unit (3): Includes ledger management subunit (31), smart contract subunit (32), and cross-chain verification interface (33); on-chain evidence storage hash, timestamp, and signature; off-chain encrypted storage of original data; key management + logical deletion to meet compliance.

[0010] 4) Intelligent control and interaction unit (4): including front-end rendering module, permission module, and API module; realizes command push, interface visualization, exception output, and source tracing query.

[0011] 2. Core Creative Collaboration

[0012] This invention is not a simple patchwork of existing technologies, but rather an organic combination of edge-side real-time filtering, off-chain encryption + on-chain hashing, and offline dual-timestamp calibration. 1) Edge verification filters out invalid / abnormal data in advance to avoid congestion and cost waste caused by garbage data being uploaded to the chain; 2) Hash data is stored on-chain, while raw data is stored off-chain, balancing immutability and privacy compliance; 3) Dual timestamps enable reliable data transmission in network outage scenarios, adapting to real-world conditions where medical networks are unstable. These three technologies work together to solve the challenge of reliable management of medical samples throughout their entire lifecycle, a problem that cannot be addressed by a single technology.

[0013] Beneficial effects

[0014] 1. Reasonable scope of protection: It does not limit a single algorithm or fixed value, and has good resistance to circumvention; 2. Complete technical solution: It is based on hardware modules and technical logic, and has clear technical attributes; 3. Strong privacy compliance: It adopts an on-chain and off-chain separation storage and key management mechanism to meet the regulatory requirements for medical data; 4. Outstanding creativity: The organic integration of edge filtering, on-chain and off-chain collaboration, and network disconnection calibration has achieved significant technological progress; 5. High scenario adaptability: Supports offline caching and online resume download, adapting to the network environment of medical sites; 6. Easy to deploy and implement: Modular architecture, low hardware dependency, and rapid deployment; 7. Convenient traceability and evidence collection: On-chain data is tamper-proof and can be directly used as a basis for traceability; 8. Clear hierarchy of rights: The sovereign and subordinate claims are reasonably matched, and the protection of technology is stable. Attached Figure Description

[0015] Figure 1 is a block diagram of the overall system architecture of the present invention; The system comprises: 1- Data acquisition unit, used to collect sample identifiers, environmental parameters, operator information, and digital signatures; 2- Edge verification unit, used to verify the legality of data and output hash digests and timestamps; 3- Blockchain evidence storage unit, including ledger management subunit 31, smart contract subunit 32, and cross-chain verification interface 33; 4- Intelligent control and interaction unit, used to provide query, control, API interaction, and result output; and 5- Off-chain distributed file system, used for encrypted storage of original sensitive data.

[0016] Figure 2 is a schematic diagram of the medical sample full life cycle traceability method of the present invention; This includes: trusted data collection and coding, edge verification and filtering, blockchain evidence storage and synchronization, and intelligent management and traceability steps.

[0017] Figure 3 is a schematic diagram of the interaction between the abnormal state handling and information output method of the present invention; It is used to realize abnormal signal reception, control command push, sample operation disabling, abnormal information output and full-link traceability query. Detailed Implementation

[0018] Example 1 (General Standard Version)

[0019] The system is used for sample management in hospital laboratory departments: The data acquisition unit (1) uses tamper-proof RFID tags to physically bind to the sample tubes to generate a unique identifier; the sensor collects temperature and humidity data, and the data is cached locally when the network is disconnected; Edge verification unit (2) monitors data fluctuation characteristics and heartbeat signals according to time windows, and immediately alarms and blocks uplink when abnormalities occur; The blockchain evidence storage unit (3) adopts a medical consortium chain, which stores hashes, double timestamps, and signatures on the chain; the original data is encrypted and stored in the off-chain distributed file system (5), and the key is managed by the medical institution; since the original data is stored with high-strength encryption, destroying the corresponding decryption key will make the original data unrecoverable in computation, thus being equivalent to physical deletion in technical effect, which meets the regulatory requirements for the right to delete data; The smart contract sub-unit (32) detects environmental anomalies or overdue transactions, automatically generates a locking instruction, and updates the on-chain status identifier; The intelligent control and interaction unit (4) outputs visual information to the terminal through API, disables abnormal sample operations, and provides a source tracing entry point.

[0020] Example 2 (Preferred parameter version, corresponding to dependent claims)

[0021] The temperature change rate threshold is set to ≤5℃ / hour, and the humidity is set to ≤10% / hour; the temperature safety threshold is 8℃, and an anomaly is triggered after 30 seconds; the verification algorithm uses differential slope. The rest is the same as in Example 1.

[0022] Example 3 (Network Disconnection Scenario)

[0023] The cold chain transportation of the sample was interrupted for 4 hours. The data acquisition unit (1) cached locally. After reconnection, the dual timestamps completed the time sequence consistency comparison and data verification. The data was automatically re-uploaded to the chain to ensure that the whole process was reliable and the time sequence was correct.

[0024] Case

[0025] A top-tier hospital adopted this system to manage blood and body fluid medical samples, covering the entire process of collection, transportation, storage, testing, and disposal. The system deployment cycle was 3 days, reducing hardware costs by 60%. It has processed over 50,000 samples, with a 100% accuracy rate in anomaly warnings, and no data tampering or privacy leaks. Due to its broad, unambiguous, and clearly defined inventive claims, similar solutions cannot circumvent it by simply changing parameters or converting laws, demonstrating significant patent stability and commercial value.

Claims

1. A blockchain-based trusted traceability system for the entire lifecycle of medical samples, characterized in that, It includes a data acquisition unit (1), an edge verification unit (2), a blockchain evidence storage unit (3), and an intelligent control and management interaction unit (4) that are connected in sequence. The data acquisition unit (1) is equipped with a processor, memory, anti-tamper electronic identification module and multi-source environmental sensors to generate a unique identification for medical samples, collect environmental parameters, operator identity information and digital signatures throughout the sample transfer process, and support local data caching in the offline state. The edge verification unit (2) is configured with an edge computing module, which is used to perform data legality verification and anomaly filtering based on the data fluctuation characteristics of environmental parameters and sensor heartbeat signals. If the verification fails, the data is rejected from being uploaded to the blockchain and an alarm is triggered. The blockchain evidence storage unit (3) adopts a consortium blockchain architecture, including a ledger management subunit (31), a smart contract subunit (32), and a cross-chain verification interface (33); the unique identifier of the sample, data hash digest, dual timestamp information, and operator digital signature are stored on the chain, and the original sensitive data is encrypted and stored in the off-chain distributed file system (5), and a key management and data logical deletion module is configured to meet medical privacy compliance. The smart contract subunit (32) is configured to monitor on-chain data in real time, and automatically generate and broadcast a state lock transaction instruction and update the sample on-chain state identifier when the preset abnormal conditions are met. The intelligent management and control interaction unit (4) realizes multi-role permission management, full life cycle traceability query and abnormal early warning information output through the application programming interface.

2. The system according to claim 1, characterized in that, The tamper-proof electronic tag module is an RFID or NFC module, equipped with a tamper-proof tag that is anti-metal, low-temperature resistant, and waterproof. The tag and the sample carrier are physically bound together, and opening the tag will cause it to become invalid or physically damaged.

3. The system according to claim 1, characterized in that, The edge verification unit (2) performs verification based on the changing trend of environmental parameters within a preset time window, and simultaneously performs sensor heartbeat detection; when the changing trend exceeds the preset threshold or there is no heartbeat signal, it is determined to be abnormal data.

4. The system according to claim 3, characterized in that, The environmental parameters include temperature and humidity; The trend of change is calculated using at least one of the differential slope, variance, standard deviation, or moving average algorithms.

5. The system according to claim 1, characterized in that, The dual timestamps include a first timestamp generated locally on the device and a second timestamp confirmed by the blockchain network. After the network is restored, the smart contract sub-unit (32) completes the data consistency verification based on the dual timestamp time sequence consistency comparison, and performs on-chain storage after the verification is passed.

6. The system according to claim 1, characterized in that, The preset abnormal conditions of the smart contract subunit (32) include: the sample environment parameters exceeding the preset threshold for a preset duration, or the sample failing to complete the node transfer within the preset time limit; when the conditions are met, the sample status is automatically marked, the transfer permission is locked, and a responsibility association identifier is generated.

7. The system according to claim 4, characterized in that, In a preferred embodiment, the temperature change rate threshold does not exceed 5°C / hour, and the humidity change rate threshold does not exceed 10% / hour.

8. The system according to claim 6, characterized in that, In a preferred embodiment, the preset temperature threshold is 8°C and the duration is 30 seconds.

9. A blockchain-based method for trusted traceability of medical samples throughout their entire lifecycle, applied to the system described in any one of claims 1-8, characterized in that, include: S1: Trusted data acquisition and coding, generating a unique identifier for the sample, collecting environmental parameters and operational information and digitally signing them, and caching offline data locally; S2: Edge verification filtering verifies the legality of data based on environmental parameter data fluctuation characteristics and sensor heartbeat signals, and generates a hash digest upon passing the verification; S3: Blockchain evidence storage synchronization stores the identifier, hash digest, dual timestamps, and digital signature on the blockchain, while the original data is encrypted and stored off-chain and key management is performed; S4: Intelligent control and traceability, smart contracts monitor in real time and automatically execute state locking and identifier updates, and the terminal realizes traceability query and anomaly output.

10. A method for handling and outputting information about abnormal states of medical samples, applied to the system described in any one of claims 1-8, characterized in that, include: S1: Receive the abnormal signal sent by the smart contract subunit (32); S2: Intelligent control and interaction unit (4) pushes control commands through API, renders hash verification identifier on the interface, and disables subsequent operations on the sample; S3: Outputs the exception time, exception parameters, responsibility association identifier, and on-chain hash link; S4: Provides a full-chain traceability query entry point and links to tamper-proof evidence data stored on the chain.

Images